Determining novel candidate anti-hepatocellular carcinoma drugs using interaction networks and molecular docking between drug targets and natural compounds of SiNiSan

BACKGROUND: SiNiSan (SNS) is an ancient traditional Chinese medicine (TCM) used to treat liver and spleen deficiencies. We studied the unique advantages of using SNS to treat hepatocellular carcinoma (HCC) with multiple components and targets to determine its potential mechanism of action. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qin, Feng, Zhangying, Gao, Mengxi, Guo, Liru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2021
Materias:
Bioinformatics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894118/
https://www.ncbi.nlm.nih.gov/pubmed/33628636
http://dx.doi.org/10.7717/peerj.10745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894118/
https://www.ncbi.nlm.nih.gov/pubmed/33628636
http://dx.doi.org/10.7717/peerj.10745

Ejemplares similares